>>> See another related interview “Microbiome and Human Metabolism”
Experimental Medicine December 2009 issue
Timothy J. Ley, M.D.
As a physician scientist, Dr. Ley has been devoted to both the treatment and the basic research of acute myeloid leukemia (AML) since 1980’s. In this interview, Dr. Ley will talk about the significance of the recent results from the first whole-genome sequencing of an AML patient, which was a landmark discovery in the field of cancer genomics. Dr. Ley will also tell us about the next strategies for cancer research, the impact of the whole-genome sequencing technology on personalized medicine, and a continuous challenge to promote translational research.
![]() |
m4v 68.4MB | ![]() |
![]() |
wmv 106MB | ![]() |
![]() |
m4v 68.1MB | ![]() |
![]() |
wmv 106MB | ![]() |
![]() |
m4v 48.7MB | ![]() |
![]() |
wmv 75.6MB | ![]() |
![]() |
m4v 61.7MB | ![]() |
![]() |
wmv 95.9MB | ![]() |
![]() |
m4v 58.9MB | ![]() |
![]() |
wmv 91.6MB | ![]() |
![]() |
m4v 50.5MB | ![]() |
![]() |
wmv 78.1MB | ![]() |